In vivo damage to chorioallantoic membrane blood vessels by porphycene-induced photodynamic therapy-Reference-Cited by-同舟云学术

In vivo damage to chorioallantoic membrane blood vessels by porphycene-induced photodynamic therapy

Published:1995-10 Issue:2-3 Volume:30 Page:115-121
ISSN:1011-1344
Container-title:Journal of Photochemistry and Photobiology B: Biology
language:en
Short-container-title:Journal of Photochemistry and Photobiology B: Biology

Author:

Gottfried Varda,Davidi Ronit,Averbuj Claudia,Kimel Sol

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Biophysics,Radiological and Ultrasound Technology,Radiation

Reference24 articles.

1. Photochemotherapy of cancer: experimental research;Moan;Photochem. Photobiol.,1992

2. Photodynamic therapy;Dougherty;Photochem. Photobiol.,1993

3. Cellular targets of photodynamic therapy as a guide to mechanism;Hilf,1992

4. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers;Star;Cancer Res.,1986

5. In-vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy;Tromberg;Photochem. Photobiol.,1990

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heavy atom-modified hemicyanine dyes as photosensitizer scaffolds combined with nitric oxide trigger the butterfly effect in tumor therapy;Dyes and Pigments;2024-09

2. Technical Implications of the Chicken Embryo Chorioallantoic Membrane Assay to Elucidate Neuroblastoma Biology;International Journal of Molecular Sciences;2023-09-29

3. The potential effect of leptin co-administration on photodynamic damage using quail chorioallantoic membrane model;Photodiagnosis and Photodynamic Therapy;2023-09

4. Multi-level optical angiography for photodynamic therapy;Biomedical Optics Express;2023-02-09

5. Bridging the In Vitro to In Vivo gap: Using the Chick Embryo Model to Accelerate Nanoparticle Validation and Qualification for In Vivo studies;ACS Nano;2022-12-01